FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to neurochemistry, pathophysiology, neurology and psychiatry. On the model of acute generalized convulsions, caused by pentylenetetrazole in Wistar male rats, the method of anticonvulsant action when applying sodium citicoline and sodium valproate is disclosed. Preparations are being intraperitoneally administered, at that, citicoline is being administered in a dose of 300 mg/kg one hour before the administration of pentylenetetrazole, sodium valproate is being administered in a dose of 70 mg/kg 10 minutes before the administration of pentylenetetrazole.
EFFECT: selected dose schedule of the preparations provides higher anticonvulsant action also related to the neuroprotective action of preparations, which reduces the neurodegeneration in the rat brain under conditions of acute generalized convulsions caused by pentylenetetrazole.
1 cl, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DISCOVERING ANTICONVULSANT ACTION OF CITICOLINE IN PENTYLENETETRAZOLE KINDLING MODEL INVOLVING MALE C57B1/6 MICE | 2014 |
|
RU2567275C1 |
N-ALKYL-TROPINES AND N-ALKYL-NORTROPINES HAVING h-LYTIC, ANTIPARKINSONIAN, ANTIEPILEPTIC, ANALGESIC AND ANTIDEPRESSANT ACTIVITY | 2014 |
|
RU2597616C2 |
3-BENZYLAMINOMETHYLENEPYRROLIDINE-2,4-DIONE AND ANTICONVULSANT AGENT BASED ON SAID | 1997 |
|
RU2144918C1 |
METHOD OF MODELLING PAROXYSMAL CONVULSIVE DISORDER | 2009 |
|
RU2434306C2 |
ANTICONVULSANT AND ANTIHYPOXIC AGENT | 2008 |
|
RU2393857C2 |
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING PAROXYSMAL CONDITIONS | 2011 |
|
RU2469722C1 |
4-BENZOYLPYRIDINE OXIME DERIVATIVES HAVING ANTICONVULSANT ACTIVITY AS AGENTS FOR TREATMENT OF EPILEPSY AND PAROXYSMAL STATES | 2016 |
|
RU2643091C2 |
DERIVATIVE PYRIDOXIN FOR TREATMENT OF EPILEPSY | 2017 |
|
RU2650523C1 |
DERIVATIVES OF 4-PHENYLPYRROLIDONE WITH ANTICONVULSANT AND NOOTROPIC ACTIVITY AS MEANS OF TREATING EPILEPSY AND PAROXYSMAL CONDITIONS | 2017 |
|
RU2748419C2 |
4-(3,4-DIBROMOTHIOPHENE CARBONYL)-2,6,8,12-TETRAACETYL-2,4,6,8,10,12-HEXAAZATETRACYCLO[5,5,0,0,0]DODECANE USED AS AN ANTICONVULSANT | 2018 |
|
RU2684107C1 |
Authors
Dates
2016-10-20—Published
2015-09-30—Filed